Amarex achieves exceptionally fast enrollment completion, ahead of schedule, for a Diabetic Neuropathy Clinical Trial

Amarex invited to join executive trade mission to India

CytoDyn Signs Agreement with Amarex Clinical Research LLC to Prepare Two Phase 2b Clinical Trial Protocols to Explore Two Additional Therapeutic Indications for PRO 140

Amarex's Dr Mukesh Kumar to conduct workshops in Argentina on preparation of non-U.S. generated clinical and manufacturing data to support US FDA approval of medical products